Iguratimod
Showing 1 - 25 of 25
Rheumatoid Arthritis Trial (Iguratimod combined with Tofacitinib;)
Not yet recruiting
- Rheumatoid Arthritis
- Iguratimod combined with Tofacitinib;
- (no location specified)
Mar 26, 2023
Rheumatoid Arthritis, Therapy Trial in Jinan (Iguratimod)
Recruiting
- Rheumatoid Arthritis
- Therapy
- Iguratimod
-
Jinan, Shandong, ChinaYanfeng Hou
Nov 24, 2023
Hand Osteoarthritis, Inflammatory Arthritis Trial (Iguratimod, )
Not yet recruiting
- Hand Osteoarthritis
- Inflammatory Arthritis
- Iguratimod
- placebo
- (no location specified)
Feb 7, 2022
Primary Sjögren's Syndrome Trial in Hangzhou (Iguratimod Tablets, Hydroxychloroquine Sulfate Tablets)
Recruiting
- Primary Sjögren's Syndrome
- Iguratimod Tablets
- Hydroxychloroquine Sulfate Tablets
-
Hangzhou, Zhejiang, ChinaSecond affiliated hospital of zhejiang university,school of medi
Mar 23, 2022
Immune Thrombocytopenia Trial in Beijing (Iguratimod)
Not yet recruiting
- Immune Thrombocytopenia
- Iguratimod
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Mar 21, 2022
Autoimmune Diseases Trial in Beijing (Diprospan plus iguratimod, Diprospan plus leflunomide, Prednisone plus leflunomide)
Recruiting
- Autoimmune Diseases
- Diprospan plus iguratimod
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
Mar 16, 2023
Arthritis, Rheumatoid Trial in Jinan (Iguratimod, Methotrexate, Adalimumab Injection)
Recruiting
- Arthritis, Rheumatoid
- Iguratimod
- +4 more
-
Jinan, Shandong, ChinaQilu Hospital
Nov 28, 2022
Arthritis, Rheumatoid Trial in Jinan (Iguratimod, MTX, HCQ)
Active, not recruiting
- Arthritis, Rheumatoid
- Iguratimod
- +3 more
-
Jinan, Shandong, ChinaQilu Hospital
Aug 7, 2021
Arthritis, Rheumatoid Trial in Jinan (Iguratimod, Tofacitinib, Pred)
Recruiting
- Arthritis, Rheumatoid
- Iguratimod
- +2 more
-
Jinan, Shandong, ChinaQilu Hospital
Jun 17, 2021
Rheumatoid Arthritis Trial in Beijing (Iguratimod)
Completed
- Rheumatoid Arthritis
- Iguratimod
-
Beijing, ChinaPeking University People's Hospital
Oct 9, 2020
Systemic Sclerosis, Diffuse Trial (Iguratimod, Placebo)
Not yet recruiting
- Systemic Sclerosis, Diffuse
- Iguratimod
- Placebo
- (no location specified)
Aug 13, 2020
Primary Sjögren Syndrome Trial in China (Iguratimod, Placebo)
Recruiting
- Primary Sjögren Syndrome
- Iguratimod
- Placebo
-
Beijing, Beijing, China
- +29 more
Jul 16, 2021
Lupus Nephritis Trial in Shanghai (Iguratimod, Cyclophosphamide, Azathioprine)
Unknown status
- Lupus Nephritis
- Iguratimod
- +3 more
-
Shanghai, Shanghai, China
- +1 more
Dec 18, 2018
Rheumatoid Arthritis Trial in Hangzhou (Tofacitinib)
Recruiting
- Rheumatoid Arthritis
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 9, 2021
Kidney Transplantation Trial in Nanjing (Iguratimod, Mycophenolate mofetil, Tacrolimus)
Unknown status
- Kidney Transplantation
- Iguratimod
- +3 more
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Aug 27, 2018
IgG4-related Disease Trial in Beijing (T 614)
Unknown status
- IgG4-related Disease
- T 614
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Apr 10, 2018
The Registry Study of Takayasu Arteritis in East China
Recruiting
- Takayasu Arteritis
- +4 more
- Tocilizumab
- Leflunomide
-
Shanghai, Shanghai, ChinaDepartment of Rheumatology in Zhongshan hospital, Fudan Universi
Aug 7, 2021
Efficacy of Iguratimod in Patients With Rheumatoid Arthritis
Completed
- Rheumatoid Arthritis
- Iguratimod
-
Aisai, Aichi, Japan
- +452 more
Nov 2, 2018
Lupus Nephritis Trial in Shanghai (Iguratimod)
Unknown status
- Lupus Nephritis
- Iguratimod
-
Shanghai, Shanghai, ChinaRenJi Hospital
Feb 23, 2017
Sjogren's Syndrome Trial in Beijing (Iguratimod)
Unknown status
- Sjogren's Syndrome
- Iguratimod
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jan 15, 2017
Rheumatoid Arthritis Trial in Shanghai (Iguratimod, Methotrexate)
Unknown status
- Rheumatoid Arthritis
- Iguratimod
- Methotrexate
-
Shanghai, ChinaRenji Hospital Affiliated to Shanghai Jiaotong University School
Feb 22, 2016
Rheumatoid Arthritis Trial in Guangzhou (Iguratimod, Iguratimod )
Unknown status
- Rheumatoid Arthritis
- Iguratimod
- Iguratimod placebo
-
Guangzhou, Guangdong, ChinaThird Affiliated Hospital Of Sun Yat-sen University
Oct 21, 2014
Rheumatoid Arthritis Trial in Beijing (Iguratimod, Leflunomide, Methotrexate)
Unknown status
- Rheumatoid Arthritis
- Iguratimod
- +2 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 23, 2014